00:03AIDES, I really like to talk about a little bit about a brand-new brand and a little bit about
00:08it.
00:10I have been told that everyone is working a lot and I have been doing a lot for it.
00:16So, for some reason, I have been doing the best advice of HIV and ARS,
00:21I have been doing the best advice of HIV and HIV.
00:29The HV AIDS has been an issue with the HV AIDS.
00:32It's been a long time since it's been a long time.
00:35So, how do you get it?
00:37I came to the HMD when I was talking about HV AIDS.
00:43I was talking about the HV AIDS in the HV AIDS.
00:46I was talking about surveillance program.
00:49I was talking about the HV AIDS.
00:54The question is, it is a very important question in the GARBINISTRAL system and HRV.
01:01This is the fact that for the government to be the director of Hiv,
01:04it is important for the public officials from the Hiv state to be the government.
01:08You know, the internet has been there for you.
01:20People in the same time,
01:22After I heard the MD, I was able to help my first exclusive HIV AIDS physician.
01:34Sir, we are doing a lot of work.
01:37We are doing a lot of work.
01:38We are doing a lot of work.
01:41We are doing a lot of work.
01:43We are doing a lot of work.
01:44We are doing a lot of work.
01:47In two years, we have 3 steps ahead.
01:53The steps ahead are going to be out of the room.
01:57Here, we are going to take a long time to get out of the room and get out of the
02:04room.
02:07This is going to take a long time.
02:14This is a very good study.
02:17Let's try this one-nate.
02:19See, patients will be able to teach the patient's practice.
02:28I will give you the patient's practice.
02:31I will give you the patient's practice.
02:36I will give you the patient's practice.
02:36Sir, I have been talking about HIV and HIV.
02:39I'm going to talk to you about the virus.
02:42I'm going to talk to you about the virus.
02:44I'm going to talk to you about the virus.
02:46The CDC is the Centers for Disease Control.
02:55It's been a long time for 3 months.
02:57I'm going to talk to you about the virus.
03:08I'm going to talk about the virus.
03:17In the first time, they had a test for the first time.
03:22Then, the patient was required for the patient to get a patient.
03:28Then, the patient got a test for the patient.
03:28In the same time, they had a test for the patient.
03:31They had a test for the patient.
03:37After all, they also added the quatre plugins and have a content.
03:44They also had a tutorial on every project, but they also added the three plugins.
03:52When this third part of each plugin, it was added to the virus load and the other one.
04:01I have a combination of three different combinations.
04:08I have two different parts.
04:12I started to use Udividin, Lamidin, Stavidin and Stavidin.
04:17So, I have two combinations of Udividin, Lamidin and Stavidin.
04:22The same thing is that the patient has exposed these two combinations.
04:28They are not able to do any of these.
04:31They are not able to do any of these two combinations.
04:40They are not able to do any of these.
04:43So, after three months, I was able to do the same thing.
04:50So, after two months, I was able to do the patient's work.
04:55So, after four months, I was able to do the ICI International Symposium on HIV and Emerging Infectious Disease Initiative.
05:08So, after three months, I was able to do the same thing.
05:15So, after three months, I was able to do the same thing.
05:18So, after two months, I was able to do the same thing.
05:27So, after three months, I was able to do the same thing.
05:39So, after three months, I was able to do the same thing.
05:55So, after three months, I was able to do the same thing.
06:00So, after three months, I was able to do the same thing.
06:14So, after three months, I was able to do the same thing.
06:26So, after three months, I was able to do the same thing.
06:28So, after four months, I was able to do the same thing.
07:01So, after three months, I was able to do the same thing.
07:04So, after four months, I was able to do the same thing.
07:10I am not sure that the HIV patient is a test for you.
07:14But the HIV patient has a test for TB.
07:18The HIV patient is not very well.
07:22It is not very well.
07:24It is very well.
07:26I have not heard about the Journal of Clinical Triberculosis and Other Mycobactyl Diseases.
07:36It was published in LCR in the journal.
07:45In India, the test is a CD4 wire-loaded test.
07:53However, the test is a CD4 wire-loaded test.
08:04So, the first thing I would like to say is that the vaccine is a very important person.
08:10Sir, we have to discuss about the vaccine and the first question about the vaccine.
08:15The question is, how do we get the vaccine?
08:19Vaccine is not a big issue, but we don't have to say that the vaccine is not a big issue.
08:25We don't have to say that the vaccine is not a big issue.
08:33going on when a man is taking a long time to remember,
08:40that is the same language in the world since the two decades.
08:47At the same time, that is the same language behind the will and that will represent the same language in
09:02the world.
09:03So, the national government has no such a strong government.
09:10This is the first time that we have to say that HIV is a vaccine.
09:15If we have to say that the virus is a vaccine,
09:21we have to say that HIV is a vaccine.
09:29like in January.
09:31That is why the vaccine is a very important issue with the vaccine.
09:39It's also been a very important issue of vaccination for the vaccine.
09:42But the vaccine is a very important issue with the vaccine.
09:47But the vaccine is a very important issue of this vaccine.
09:58In the country, we have to get the vaccine to get the vaccine, and we have to get the vaccine
10:08to get the vaccine.
10:09Sir, do you want to get the vaccine to get the vaccine?
10:14I have a lot of problems.
10:17There are now some paralysis.
10:34So, when I am talking about HIV in India, the research, that is the study of HIV in the field.
10:52This is the Indian Medical Association journal.
10:54That's why the AIMSWA approach from G20,
10:56the National Medical Journal of India,
10:58has already said this to me.
11:03Today's winter, we have been talking about HIV and AIDS.
11:07We have been talking about this great advice and I'm talking about this.
11:13There is also an issue of issues.
11:21You
Comments